Supplement labeling

New York Senate bill (SB 4909) would require all dietary supplements to contain a statement in their labeling "clearly discernible to a customer" disclosing whether "the product has or has not been tested by [FDA]." The statement would accompany the FDA disclaimer regarding structure/function claims required under the Dietary Supplement Health & Education Act. The bill was introduced in the Senate April 20 and has been referred to the Committee on Consumer Protection